FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313334469> ?p ?o ?g. }

• W4313334469 endingPage "104205" @default.
• W4313334469 startingPage "104205" @default.
• W4313334469 abstract "Flunixin meglumine (FM), a nonselective cyclooxygenase (COX) inhibitor, is most frequently selected for the treatment of equine systemic inflammatory response syndrome (SIRS)/endotoxemia. However, FM has considerable adverse effects on gastrointestinal function. The aims of this study were to compare the effect of meloxicam (MX), a COX-2 selective inhibitor commonly used in equine clinical practice, with FM, and to investigate the potential for clinical application in horses with SIRS/endotoxemia. Fifteen horses were divided into three groups of five and orally administered MX (0.6 mg/kg), FM (1.1 mg/kg), or saline as placebo at 30 minutes after LPS challenge. Clinical parameters, including behavioral pain scores, were recorded and blood for clinical pathological data was collected at various times from 60 minutes before to 420 minutes after LPS infusion. The pain score were significantly lower in both the MX and FM groups than in the placebo group, with no significant difference between them. Body temperature was significantly lower in the MX and FM groups than in the placebo group. Heart rates and respiratory rates, hoof wall surface temperature, and leukocyte counts changed similarly between the MX and FM groups. TNF-α and cortisol were lower in the FM group than in the MX group. The results suggest that MX suppresses the inflammatory response after LPS infusion and has an analgesic effect similar to that of FM. Given the adverse effects of nonselective COX inhibitors, clinical application of MX may be beneficial in horses with SIRS/endotoxemia." @default.
• W4313334469 created "2023-01-06" @default.
• W4313334469 creator A5003301522 @default.
• W4313334469 creator A5017603302 @default.
• W4313334469 creator A5025519045 @default.
• W4313334469 creator A5034246554 @default.
• W4313334469 creator A5038489360 @default.
• W4313334469 creator A5049508199 @default.
• W4313334469 creator A5063671736 @default.
• W4313334469 creator A5076101957 @default.
• W4313334469 date "2023-02-01" @default.
• W4313334469 modified "2023-10-16" @default.
• W4313334469 title "Oral Administration of Meloxicam and Flunixin Meglumine Have Similar Analgesic Effects After Lipopolysaccharide-Induced Inflammatory Response in Thoroughbred Horses" @default.
• W4313334469 cites W1574699893 @default.
• W4313334469 cites W1922771540 @default.
• W4313334469 cites W1945898151 @default.
• W4313334469 cites W1978618460 @default.
• W4313334469 cites W1997442489 @default.
• W4313334469 cites W2004213488 @default.
• W4313334469 cites W2008690714 @default.
• W4313334469 cites W2036473753 @default.
• W4313334469 cites W2044737450 @default.
• W4313334469 cites W2060297579 @default.
• W4313334469 cites W2063151186 @default.
• W4313334469 cites W2068563251 @default.
• W4313334469 cites W2073134798 @default.
• W4313334469 cites W2082630924 @default.
• W4313334469 cites W2106370930 @default.
• W4313334469 cites W2107754755 @default.
• W4313334469 cites W2124290573 @default.
• W4313334469 cites W2141913015 @default.
• W4313334469 cites W2492237861 @default.
• W4313334469 cites W2622520881 @default.
• W4313334469 cites W2789881166 @default.
• W4313334469 cites W2888800657 @default.
• W4313334469 cites W2922896425 @default.
• W4313334469 cites W2977726532 @default.
• W4313334469 cites W3012570259 @default.
• W4313334469 cites W3016816233 @default.
• W4313334469 cites W3059410396 @default.
• W4313334469 cites W3197601956 @default.
• W4313334469 cites W4212980523 @default.
• W4313334469 doi "https://doi.org/10.1016/j.jevs.2022.104205" @default.
• W4313334469 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36586521" @default.
• W4313334469 hasPublicationYear "2023" @default.
• W4313334469 type Work @default.
• W4313334469 citedByCount "0" @default.
• W4313334469 crossrefType "journal-article" @default.
• W4313334469 hasAuthorship W4313334469A5003301522 @default.
• W4313334469 hasAuthorship W4313334469A5017603302 @default.
• W4313334469 hasAuthorship W4313334469A5025519045 @default.
• W4313334469 hasAuthorship W4313334469A5034246554 @default.
• W4313334469 hasAuthorship W4313334469A5038489360 @default.
• W4313334469 hasAuthorship W4313334469A5049508199 @default.
• W4313334469 hasAuthorship W4313334469A5063671736 @default.
• W4313334469 hasAuthorship W4313334469A5076101957 @default.
• W4313334469 hasConcept C126322002 @default.
• W4313334469 hasConcept C142724271 @default.
• W4313334469 hasConcept C181199279 @default.
• W4313334469 hasConcept C185592680 @default.
• W4313334469 hasConcept C197934379 @default.
• W4313334469 hasConcept C204787440 @default.
• W4313334469 hasConcept C27081682 @default.
• W4313334469 hasConcept C2778754761 @default.
• W4313334469 hasConcept C2779689624 @default.
• W4313334469 hasConcept C2779751750 @default.
• W4313334469 hasConcept C2780820201 @default.
• W4313334469 hasConcept C42219234 @default.
• W4313334469 hasConcept C55493867 @default.
• W4313334469 hasConcept C71924100 @default.
• W4313334469 hasConcept C98274493 @default.
• W4313334469 hasConceptScore W4313334469C126322002 @default.
• W4313334469 hasConceptScore W4313334469C142724271 @default.
• W4313334469 hasConceptScore W4313334469C181199279 @default.
• W4313334469 hasConceptScore W4313334469C185592680 @default.
• W4313334469 hasConceptScore W4313334469C197934379 @default.
• W4313334469 hasConceptScore W4313334469C204787440 @default.
• W4313334469 hasConceptScore W4313334469C27081682 @default.
• W4313334469 hasConceptScore W4313334469C2778754761 @default.
• W4313334469 hasConceptScore W4313334469C2779689624 @default.
• W4313334469 hasConceptScore W4313334469C2779751750 @default.
• W4313334469 hasConceptScore W4313334469C2780820201 @default.
• W4313334469 hasConceptScore W4313334469C42219234 @default.
• W4313334469 hasConceptScore W4313334469C55493867 @default.
• W4313334469 hasConceptScore W4313334469C71924100 @default.
• W4313334469 hasConceptScore W4313334469C98274493 @default.
• W4313334469 hasFunder F4320334764 @default.
• W4313334469 hasLocation W43133344691 @default.
• W4313334469 hasLocation W43133344692 @default.
• W4313334469 hasOpenAccess W4313334469 @default.
• W4313334469 hasPrimaryLocation W43133344691 @default.
• W4313334469 hasRelatedWork W1583328852 @default.
• W4313334469 hasRelatedWork W1983403674 @default.
• W4313334469 hasRelatedWork W1996548929 @default.
• W4313334469 hasRelatedWork W2020363335 @default.
• W4313334469 hasRelatedWork W2032043921 @default.
• W4313334469 hasRelatedWork W2079786372 @default.
• W4313334469 hasRelatedWork W2083036447 @default.

• next